TL;DR
National health insurers are actively restructuring their business models to insulate themselves from volatile, government-sponsored programs while aggressively leveraging their unregulated, vertically integrated service segments to sustain enterprise profitability. This strategic pivot is supported by key federal court victories that shield integrated pharmacy benefit manager (PBM) structures from aggressive state-level dismantle attempts. As underwriting margins in Medicare Advantage and Medicaid contract, internal services like Optum and Carelon are proving to be the industry's ultimate economic shock absorbers.
The Retreat from Government Risk to Unregulated Services
Major managed care organizations are aggressively scaling back their exposure to volatile, government-sponsored health plans, preferring to channel capital and volume into their highly profitable, vertically integrated clinical and service arms.
"As we continue our assessment, we expect to exit additional Medicaid markets over the next 12-18 months where we do not see a path to sustainable performance..." — [Elevance Health: Carelon and the Internal Profit Engine
]
"Seniors served through Medicare Advantage contracted by 965,000 since year-end 2025 (falling to 7.565 million from 8.445 million)." — [UnitedHealth and Optum Vertical Integration
This strategic shift demonstrates that underwriting volume is no longer the primary driver of managed care success; rather, profitability is maintained by capturing multiple margin points across internal delivery chains. Elevance Health's Q2 2026 results showed a dramatic divergence, with its Health Benefits operating gain collapsing by 42.6% year-over-year to $896 million, while its Carelon services and PBM arm generated $948 million, outperforming the entire insurance business for the first time in a non-Q4 quarter [Elevance Health: Carelon and the Internal Profit Engine]. By walking away from unprofitable, highly regulated members and routing remaining patient flows through internal clinical, PBM, and technology channels, conglomerates are successfully insulating their consolidated earnings from state and federal rate pressures.
What to watch: Watch for whether Elevance's planned exits from additional state Medicaid markets over the next 12 to 18 months trigger a broader, industry-wide retrenchment from government-sponsored risk [Elevance Health: Carelon and the Internal Profit Engine].
The Federal Judicial Shield for PBM Integration
National insurers are successfully leveraging federal preemption in the courts to protect their highly integrated pharmacy benefit manager structures from aggressive state-level legislation designed to dismantle them.
"The Eighth Circuit held that these geographic mandates 'bulldozed through' Congressional objectives under ERISA by disrupting plan administration uniformity. The court noted that the practical effect of the law was to 'requir[e] PBMs to tailor and retailor their networks — and perhaps even build new brick-and-mortar pharmacies — to comply with a set of exacting particularities.'" — [PBM Vertical Integration
]
This legal barrier demonstrates that the federal judiciary remains a formidable line of defense for the managed care industry. By utilizing ERISA preemption to invalidate state geographic pharmacy network rules, as seen in the landmark Flowers v. Caremark PCS Health, LLC appellate decision on June 29, 2026, courts are preventing local regulators from disrupting uniform, national PBM operations [PBM Vertical Integration]. This federal protection ensures that conglomerates can defend their vertical intersegment transactions against state-level structural divestiture laws, such as Tennessee's Fair RX Act, which seeks to prohibit PBMs from owning or operating retail, mail-order, or specialty pharmacies [PBM Vertical Integration
].
What to watch: Watch for the federal district court's decision in the Middle District of Tennessee on the lawsuits filed by CVS Caremark, Cigna's Express Scripts, and the PCMA challenging the constitutionality of Tennessee's Fair RX Act [PBM Vertical Integration].
What surprised us
- Optum's analytical and technology margins surged past 25%. While UnitedHealth Group's insurance segment absorbed a sequential loss of 525,000 members, its Optum Insight division expanded its operating margin to a staggering 25.3%, generating $1.4 billion in operating earnings [UnitedHealth and Optum Vertical Integration
- Elevance's Medicaid business is projected to lose money for the entire year. Despite its massive enterprise scale, Elevance's CFO reiterated that the company expects its Medicaid operating margin to finish 2026 at negative 1.75% [Elevance Health: Carelon and the Internal Profit Engine
- PBMs are using the Takings Clause to fight state ownership bans. In their legal battle against Tennessee's Fair RX Act, CVS Caremark and Express Scripts have introduced a novel constitutional defense, arguing that forcing them to divest highly integrated, long-held pharmacy business units constitutes an unconstitutional "taking" of private property without just compensation [PBM Vertical Integration